178 related articles for article (PubMed ID: 2545460)
1. Rapid desensitization and down-regulation of 5-HT2 receptors by DOM treatment.
Leysen JE; Janssen PF; Niemegeers CJ
Eur J Pharmacol; 1989 Apr; 163(1):145-9. PubMed ID: 2545460
[TBL] [Abstract][Full Text] [Related]
2. 5-HT2 receptors, roles and regulation.
Leysen JE; Pauwels PJ
Ann N Y Acad Sci; 1990; 600():183-91; discussion 192-3. PubMed ID: 2252309
[TBL] [Abstract][Full Text] [Related]
3. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
Pranzatelli MR
Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
[TBL] [Abstract][Full Text] [Related]
4. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
Fone KC; Johnson JV; Bennett GW; Marsden CA
Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
[TBL] [Abstract][Full Text] [Related]
5. Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors.
Buckholtz NS; Zhou DF; Freedman DX
Life Sci; 1988; 42(24):2439-45. PubMed ID: 3374263
[TBL] [Abstract][Full Text] [Related]
6. [3H]DOB: a specific agonist radioligand for 5-HT2 serotonin receptors.
Titeler M; Herrick K; Lyon RA; McKenney JD; Glennon RA
Eur J Pharmacol; 1985 Oct; 117(1):145-6. PubMed ID: 4085543
[No Abstract] [Full Text] [Related]
7. Behavioural and biochemical evidence that glucocorticoids are not involved in DOI-elicited 5-HT2 receptor down-regulation.
Chaouloff F; Baudrie V; Coupry I
Eur J Pharmacol; 1993 Nov; 249(1):117-20. PubMed ID: 8282013
[TBL] [Abstract][Full Text] [Related]
8. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Titeler M; Lyon RA; Davis KH; Glennon RA
Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
[TBL] [Abstract][Full Text] [Related]
9. Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
Titeler M; Lyon RA; Glennon RA
Psychopharmacology (Berl); 1988; 94(2):213-6. PubMed ID: 3127847
[TBL] [Abstract][Full Text] [Related]
10. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
Lyon RA; Davis KH; Titeler M
Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
[TBL] [Abstract][Full Text] [Related]
11. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
Willins DL; Meltzer HY
J Pharmacol Exp Ther; 1997 Aug; 282(2):699-706. PubMed ID: 9262333
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
Glennon RA; Young R; Rosecrans JA
Eur J Pharmacol; 1983 Jul; 91(2-3):189-96. PubMed ID: 6617740
[TBL] [Abstract][Full Text] [Related]
13. Serotonin excitation of facial motoneurons: receptor subtype characterization.
Rasmussen K; Aghajanian GK
Synapse; 1990; 5(4):324-32. PubMed ID: 2360199
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist.
Rinaldi-Carmona M; Bouaboula M; Congy C; Oury-Donat F; Simiand J; Shire D; Casellas P; Soubrié P; Brelière JC; Le Fur G
Eur J Pharmacol; 1993 Jun; 246(1):73-80. PubMed ID: 8354344
[TBL] [Abstract][Full Text] [Related]
15. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
Sanders-Bush E; Burris KD; Knoth K
J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
[TBL] [Abstract][Full Text] [Related]
16. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
[TBL] [Abstract][Full Text] [Related]
17. Rapid desensitization and resensitization of 5-HT2 receptor mediated phosphatidyl inositol hydrolysis by serotonin agonists in quiescent calf aortic smooth muscle cells.
Pauwels PJ; Van Gompel P; Leysen JE
Life Sci; 1990; 47(22):2009-19. PubMed ID: 2273941
[TBL] [Abstract][Full Text] [Related]
18. Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane.
Glennon RA; Young R; Benington F; Morin RD
J Med Chem; 1982 Oct; 25(10):1163-8. PubMed ID: 7143352
[TBL] [Abstract][Full Text] [Related]
19. Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats.
Takao K; Nagatani T; Kitamura Y; Yamawaki S
Eur J Pharmacol; 1997 Aug; 333(2-3):123-8. PubMed ID: 9314024
[TBL] [Abstract][Full Text] [Related]
20. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
Branchek T; Adham N; Macchi M; Kao HT; Hartig PR
Mol Pharmacol; 1990 Nov; 38(5):604-9. PubMed ID: 2233697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]